全文获取类型
收费全文 | 8682篇 |
免费 | 587篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 301篇 |
妇产科学 | 291篇 |
基础医学 | 935篇 |
口腔科学 | 161篇 |
临床医学 | 950篇 |
内科学 | 1874篇 |
皮肤病学 | 231篇 |
神经病学 | 861篇 |
特种医学 | 230篇 |
外科学 | 1406篇 |
综合类 | 172篇 |
一般理论 | 3篇 |
预防医学 | 422篇 |
眼科学 | 136篇 |
药学 | 647篇 |
中国医学 | 70篇 |
肿瘤学 | 576篇 |
出版年
2023年 | 43篇 |
2022年 | 101篇 |
2021年 | 221篇 |
2020年 | 105篇 |
2019年 | 197篇 |
2018年 | 235篇 |
2017年 | 166篇 |
2016年 | 186篇 |
2015年 | 253篇 |
2014年 | 313篇 |
2013年 | 434篇 |
2012年 | 562篇 |
2011年 | 627篇 |
2010年 | 386篇 |
2009年 | 359篇 |
2008年 | 522篇 |
2007年 | 517篇 |
2006年 | 530篇 |
2005年 | 461篇 |
2004年 | 447篇 |
2003年 | 326篇 |
2002年 | 310篇 |
2001年 | 278篇 |
2000年 | 217篇 |
1999年 | 218篇 |
1998年 | 65篇 |
1997年 | 61篇 |
1996年 | 57篇 |
1995年 | 34篇 |
1994年 | 47篇 |
1993年 | 46篇 |
1992年 | 100篇 |
1991年 | 102篇 |
1990年 | 105篇 |
1989年 | 98篇 |
1988年 | 81篇 |
1987年 | 71篇 |
1986年 | 58篇 |
1985年 | 56篇 |
1984年 | 54篇 |
1983年 | 37篇 |
1982年 | 16篇 |
1981年 | 25篇 |
1980年 | 20篇 |
1979年 | 40篇 |
1978年 | 23篇 |
1977年 | 20篇 |
1976年 | 23篇 |
1975年 | 19篇 |
1974年 | 23篇 |
排序方式: 共有9371条查询结果,搜索用时 15 毫秒
131.
Li-Shan Ke Wen-Yu Hu Ching-Yu Chen Chieh-Yu Liu Tai-Yuan Chiu 《Patient education and counseling》2021,104(4):815-825
ObjectiveThis study sought to develop a decision aid with cartoon pictures and evaluate its effectiveness in increasing consistency between elderly individuals and their surrogates regarding end-of-life care.MethodsA pre-post quasi-experimental design was adopted using the Life Support Preferences Questionnaire. The intervention had two components: (1) increasing participants’ knowledge of medical treatments related to end-of-life care, and (2) sharing their end-of-life wishes. The experimental group received an intervention, whereas the control group received usual care.ResultsA total of 110 participants in 55 pairs of elderly individuals with average aged 86.4 and their surrogates (27 in the experimental group, 28 in the control group) were recruited from a veterans hospital in northern Taiwan. Nearly 90 % of elderly individuals were male. The multiple linear regression showed that the inconsistent gap between elderly individuals and their surrogates in the experimental group decreased 12 points than the control group after controlling the covariances (B = ?12.116, p = 0.032).ConclusionThe intervention improved the consistency between elderly individuals and their surrogates regarding end-of-life care.Practice implicationsA decision aid with cartoon pictures may support the discussion of end-of-life care in older Asian populations. 相似文献
132.
133.
134.
ABSTRACT: BACKGROUND: AMP-activated protein kinase (AMPK) has recently been considered as a potential target for cancer therapy. However, the expression status of various subunits of the heterotrimeric AMPK in human cancers is rarely reported. We decided to determine their expressions in ovarian carcinomas and their relationships with the disease. METHODS: Expressions and locations of the AMPK-alpha1, -alpha2, -beta1, -beta2, -gamma1 and -gamma2 were detected by quantitative PCR (Q-PCR) and immunohistochemical staining (IHC). Their expression levels in ovarian tumors were compared with normal controls and also correlated with clinicopathological parameters. RESULTS: Except AMPK-alpha1, expressions of the other five AMPK subunits are significantly higher in ovarian carcinomas as determined by Q-PCR. Although IHC detection of AMPK-gamma1 and -gamma2 were not successful, over-expressions of AMPK-alpha2, -beta1, and -beta2 were further confirmed by IHC. Over-expressions of various AMPK subunits occurred independently and were mainly detected in the cytoplasm. Interestingly, AMPK-alpha2 and -beta1 were also detected in the nucleus and cell membrane, respectively. Clinical correlation analyses indicate that expressions of different AMPK subunits are associated with different subtypes of carcinoma. High expression of AMPK-alpha2 is significantly associated with endometrioid carcinomas. On the other hand, high expressions of AMPK-beta and -gamma subunits are associated with mucinous and serous carcinomas, respectively. Furthermore, high expressions of AMPK-beta1 and -gamma2 are also associated with early and late stages of disease, respectively. Finally, patients with high expression of AMPK-alpha2 had better prognosis. CONCLUSIONS: Aberrant expressions of AMPK subunits may play important roles in ovarian carcinogenesis. Each AMPK subunit may have its own function other than just a component of the AMPK molecule. Correlations with clinical parameters suggest that expressions of AMPK subunits have different clinical implications in ovarian cancer development. 相似文献
135.
136.
Shao-Wen Hung Ching-Feng Chiu Tai-An Chen Chiao-Li Chu Chi-Chang Huang Lie-Fen Shyur Chi-Ming Liang Shu-Mei Liang 《Breast cancer research and treatment》2012,136(1):89-105
Breast cancer is one of the most common cancers in women worldwide and metastasis is the major cause of breast cancer death. Development of new therapeutic agents for inhibiting breast cancer metastasis is therefore an urgent need. We previously demonstrated that recombinant DNA-derived viral capsid protein VP1 (rVP1) of foot-and-mouth disease virus-induced apoptosis of MCF-7 breast cancer cells in vitro. Here, we investigated whether rVP1 exhibits any inhibitory effects on migration/metastasis and human epidermal growth factor receptor 2 (HER-2), a well-known biomarker for poor prognosis of breast cancer. The effects of rVP1 on cancer cell migration/invasion and metastasis were evaluated using Transwell migration assay and animal cancer models of metastasis. Western blotting, RT-PCR, flow cytometry, immunohistochemistry, and immunofluorescence staining techniques were used to investigate the effects of rVP1 on HER-2 and signal transduction mediators. Non-cytotoxic concentrations of rVP1-induced mesenchymal-epithelial transition and significantly suppressed AP-2?? and HER-2 expression as well as the migration and invasion of a variety of breast cancer cell lines in a ??1-integrin-dependent manner in vitro. Gross and histopathologic examinations showed that rVP1 also suppressed metastasis of several breast cancer cell lines, including HER-2-overexpressing SK-BR-3 and BT-474 cells to lung, liver, or peripheral lymph node in orthotopic allograft/xenograft murine models. In addition, rVP1 significantly prolonged survival in breast cancer-bearing mice. Notably, no apparent side effects of rVP1 were detected, as shown by normal complete blood count levels and serum biochemistry profiles, including AST, ALT, BUN, and creatine. This study demonstrates that rVP1 suppresses the migration, invasion, and metastasis of breast cancer cells via binding to ??1 integrin receptor and down-regulation of AP-2?? and HER-2 expression. The effectiveness of rVP1 on inhibiting migration/metastasis of breast cancer and HER-2 expression suggests that it may be suitable for serving as potential therapeutics for metastatic breast cancer particularly HER-2-overexpressing cancer. 相似文献
137.
138.
139.
140.